Navigation Links
DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
Date:6/7/2008

oMark is an FDA approved test for monitoring intermediate glycemic control by measuring the levels of a monosaccharide 1,5-anhydroglucitol (1,5- AG) in blood. Multiple published studies in peer-reviewed journals have shown that the 1,5-AG test is a specific index of postprandial hyperglycemia (elevated after-meal glucose levels) and short-term glycemic control - providing a useful complement to A1C testing. GlycoMark is being used in clinical practices nationwide and is available at major reference laboratories including Quest Diagnostics, LabCorp, Esoterix, Mayo Medical Laboratories, ARUP Laboratories, and Specialty Laboratories. The test is also available at most major contract research organizations for pharmaceutical research studies.

GlycoMark was recently included in the International Diabetes Federation (IDF) Global Diabetes Care Guidelines as an emerging tool to measure after-meal glucose levels.

GlycoMark, Inc. is based in New York, New York and Winston-Salem, North Carolina.


'/>"/>
SOURCE GlycoMark, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
4. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
5. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...swire/ -- CeloNova BioSciences, Inc., a provider o... and of specialty implants, today announced that B...dical director of Baptist Cardiac & Vascular I...IA(TM) Stent System with NanoThin Polyzene®-F...s Conference to be held at the Hotel David InterCo...
(Date:12/1/2009)...swire/ -- MedNet Solutions, a global life sciences...ical study management systems, today announced tha...nical technology solution, has been certified by t...(CDISC) as complying with the Operational Data Mod... MedNet,s commitment to streamlining the entire cl...
(Date:12/1/2009)... Cumberland Pharmaceutica...ndependently conducted study of Acetadote ( acetyl...ine, as a cost-saving treatment for acetaminophen ...the peer-reviewed Journal of Medical Economics ,...t Acetadote is a less costly treatment regimen tha...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Three Cortiva Students Winners of Massage Therapy Foundation Student Case Report Awards 51223 1Three Cortiva Students Winners of Massage Therapy Foundation Student Case Report Awards 51223 2Business Opportunities in Spains Fast Growing Biotechnology Industry 12960 1Business Opportunities in Spains Fast Growing Biotechnology Industry 12960 2Withdrawal syndrome after consumption of Spice Gold 51219 1
...s no additional very late stent thrombosis, NATIC...ntific Corporation (NYSE: BSX ) today announced f...cal trial, demonstrating continued,long-term safet... stent,system. Among the findings, the TAXUS stent...rs four and five, while the bare-metal control,exp...
...pt. 3 Clinical investigators at the,European Soci...) reported,today that the CYPHER(R) Sirolimus-elut...enefits compared to a bare metal stent in the E-SI...differences in safety. At five-year follow-up, th... continued to be significantly less likely than th...
Other Medicine Technology:Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 2Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 3Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 5
(Date:12/1/2009)...ery preterm births more likely, British study find...- Pregnant women who are poor are more likely to d...n, even though both groups typically receive equal...ity of Leicester research team said their findings... between economic status and preterm birth. , F...
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...he CAEAR Foundation, one of the largest national H...to HealthHIV and launching a new website. The anno...t of a campaign to promote the organization’..., , , , ,“HealthHIV clearly, quickly and ea...
(Date:12/1/2009)...Y, Dec. 1 The government of Mexico...center for biomedical and nanomedical research, ca... research and development will be integrated with ...top Spanish speaking university in the world. The... in 2010, has been designed by the internationally...
(Date:12/1/2009)... Mich., Dec. 1 First Me...t Mercury" or the "Company") announced today that ...ed a quarterly cash dividend of $0.025 per share, ...cord at the close of business on December 15, 2009...on ,, First Mercury Financial Corporation prov...
(Date:12/1/2009)...ss affirming, isolating behaviors jump from frien...ay News) -- A new study suggests that lonely peopl...o feel lonely, too. , "Loneliness can spread fr...es of separation," said James H. Fowler, co-author...he Journal of Personality and Social Psychology ,...
Breaking Medicine News(10 mins):Health News:More Preemies Born Among the Poor 2Health News:National HIV Non-Profit Announces New Name 2Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3
... 1 Aurora St. Luke,s Medical Center has been na..." by Nursing Professionals magazine. , , The to...nclude nurses at all organizational levels in orde...on. , , "Nurses are critical to patient care at t...
... A study in the Feb. 1 issue of the journal SLEEP...nges in the levels of specific cytokines that are ... suggest that inflammation may be the pathway link...cent increase in C-reactive protein (CRP) levels a...
...on Helps Dialysis Patients Develop a Menu Game Pla... leading provider of kidney care services for thos...kidney failure, offers kidney patients a chance to...ntegral part of managing chronic kidney disease an...
...ttle effect, but active practice plays a role, stu... News) -- People who regularly attend religious se...others, a Canadian study suggests. , University of...spirituality, religious worship and suicidal behav...
.... 30 The Kroger Co. (NYSE: KR ),said today it i...tail stores,because the product was associated wit...America and may be contaminated with Salmonella. ,...y,s,King Soopers, Smith,s, Dillons, QFC, City Mark...
... Jan. 30 Attending a meeting with President Barac...al labor leaders, UAN President Ann Converso, RN, ...se as she hailed the new president,s early commitm... "For nurses, union representation is critically i...
Other Medicine News:Health News:Study suggests that inflammation may be the link between extreme sleep durations and poor health 2Health News:DaVita.com Promotes Kidney-Friendly Foods for Super Bowl(R) XLIII 2Health News:DaVita.com Promotes Kidney-Friendly Foods for Super Bowl(R) XLIII 3Health News:Kroger Recalls Nut Topping Due to Possible Health Risk 2
VersaStep™ Plus Instrument
...e Step™ and Mini Step™ device componen...ini Step™ Single Use System is supplied ster...n various configurations and combinations. They ar...ation and Access needle and the Step™ radial...
...e Step™ and Mini Step™ device componen...ini Step™ Single Use System is supplied ster...n various configurations and combinations. They ar...ation and Access needle and the Step™ radial...
...e VersaStep™ 5 mm and VersaStep™ PLUS ...ss port are supplied in separate packages. The ra...r with either a 5 mm or 5 mm PLUS valve. Insuffla... mm, 7/8 mm, 10 mm and 12 mm dilators are packaged...
Medicine Products: